CUE Stock Analysis: Buy, Sell, or Hold?
CUE - Cue Biopharma, Inc.
$23.89
-1.91 (-7.40%)
▼
5d:
-21.52%
30d:
+3.82%
90d:
+8699.26%
WAIT
LOW Confidence
Analysis Updated: Jun 16, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When CUE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CUE is down 21.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CUE is down 21.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CUE is currently trading at $23.89, which is considered fair relative to its 30-day fair value range of $21.46 to $29.61.
Technical Outlook: Technically, CUE is in a strong uptrend. Immediate support is located at $21.84, while resistance sits at $32.60. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $115.00 (+381.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CUE is in a strong uptrend. Immediate support is located at $21.84, while resistance sits at $32.60. Short-term momentum is weak, with the stock down 7.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $115.00 (+381.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$21.46 -
$29.61
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.4%)
- BULLISH: Trading 381.4% below Wall St target ($115.00)
- WARNING: Recommendation downgraded due to -21.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$21.46 -
$29.61
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$21.84
Resistance Level
$32.60
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.53
Wall Street Target
$115.00
(+381.4%)
Revenue Growth (YoY)
1250.6%
Profit Margin
-59.7%
Share & Embed Analysis
Last updated: June 16, 2026 10:50 PM ET
Data refreshes hourly during market hours. Next update: 11:50 PM
Data refreshes hourly during market hours. Next update: 11:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CUE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 63 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$102 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 60 BUY |
